Regenerative medicine nears banner year with $14.1B cash infusion, regulatory milestones and a well-stocked pipeline



Gene therapies and gene-modified cell therapy products are on track to notch the highest annual number of regulatory approvals in 2021. (LuckyStep48/Getty Images)
https://www.fiercebiotech.com/biotech/regenerative-medicine-nearing-a-banner-year-14-1b-cash-infusion-regulatory-milestones-and-a

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.